Aclarion(NASDAQ) ACONW

Market CapN/A

Since IPO (2022)-97%

5 YearN/A

1 Year-38%

1 Month+5%

$0.03

-0.39%

-0.00Today

Aclarion last closing stock price
Metric	Price	Date
Last close	USD 0.03	2026-08-31

Aclarion stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-15.33%	USD 0.03	2026-08-24
1 month	+4.53%	USD 0.02	2026-07-30
3 month	-5.93%	USD 0.03	2026-06-02
Year to date	-32.98%	USD 0.04	2025-12-31
1 year	-37.75%	USD 0.04	2025-08-29
3 year	-57.67%	USD 0.06	2023-09-01
Since inception	-96.53%	USD 0.73	2022-04-22

Aclarion Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$83.77K

Net Income (TTM)

-$9.20M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.03

Volume

2,466

Open

$0.03

Price

$0.03

Volume

2,466

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.02 - $0.23

Estimated Earnings Date

Dec 2, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.03

Volume

2,466

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.02 - $0.23

Estimated Earnings Date

Dec 2, 2026

ACONW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aclarion

Aclarion, Inc. is a healthcare technology firm focused on software development for magnetic resonance spectroscopy (MRS) in the U.S. market. The company’s flagship product, the NOCISCAN-LS Post-Processor suite, is designed to enhance clinical decision-making and quantify degenerative pain biomarkers.

Products and Services

NOCISCAN-LS Post-Processor suite for MRS data analysis
NOCICALC-LS for quantifying degenerative pain biomarkers
NOCIGRAM-LS, a clinical decision support tool

Growth Outlook

Significant market potential in healthcare technology sector
Continued investment in research and development to enhance product offerings
Strategic partnerships may drive future revenue growth

Financial Highlights

Recent quarterly revenue of $21,140, reflecting ongoing operational challenges
Cash and cash equivalents increased to $19,004,976, providing liquidity
Current ratio of 19.65 indicates strong short-term financial health

Aclarion, Inc. operates in a niche market with a focus on innovative healthcare solutions. The company has made strides in developing its flagship products, which are essential for improving patient outcomes in pain management. Despite facing operational challenges reflected in recent financial results, the company maintains a robust cash position, allowing for continued investment in product development and market expansion. The healthcare technology sector presents significant growth opportunities, and Aclarion's strategic initiatives may position it favorably for future success.

AI Generated • Aug 5, 2026

Industry

Health Care Technology

Sector

Health Care

Headquarters

Broomfield, CA 80021, US

ACONW Financials

Key Financial Metrics (TTM)

Gross Margin

-50.96%

Operating Margin

-11592.14%

Net Income Margin

-10978.48%

Return on Equity

-59.34%

Return on Capital

-54.95%

Return on Assets

-50.98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

2.47K

Avg. Volume

31.30K

Financials (TTM)

Gross Profit

-$42.69K

Operating Income

-$9.71M

EBITDA

-$8.95M

Operating Cash Flow

-$8.09M

Capital Expenditure

$571.00

Free Cash Flow

-$8.09M

Cash & ST Invst.

$16.29M

Total Debt

$0.00

Aclarion Performance Analysis

Aclarion sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-2.0%
Q4	2025-12-31	-2.4%
Q1	2026-03-31	14.4%
Q2	2026-06-30	19.2%

Aclarion sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-6.6%
Q4	2025-12-31	24.6%
Q1	2026-03-31	39.4%
Q2	2026-06-30	16.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$25.21K

+30.5%

Gross Profit

$8.30K

+61.4%

Gross Margin

32.91%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$2.75M

-71.6%

EBITDA

-$2.69M

-73.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$16.29M

+26.6%

Total Debt

$0.00

N/A

Accounts Receivable

$28.17K

+34.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-50.98%

N/A

Return on Invested Capital

-57.11%

N/A

Free Cash Flow

-$2.61M

-39.7%

Operating Cash Flow

-$2.66M

-42.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MDXLMedixall Group, Inc.

MDXLMedixall Group, Inc.$0.00+0.00%

ORHBORHub, Inc.

ORHBORHub, Inc.$0.00+0.00%

OLMMOneLife Technologies Corp.

OLMMOneLife Technologies Corp.$0.00+0.00%

APYIAspyra Inc.

APYIAspyra Inc.$0.00+0.00%

ICCTiCoreConnect Inc.

ICCTiCoreConnect Inc.$0.00+0.00%

NHELNatural Health Farm Holdings Inc.

NHELNatural Health Farm Holdings Inc.$0.00+0.00%

FDBHFounders Bay Holdings

FDBHFounders Bay Holdings$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About ACONW

What is the current price of Aclarion?

Aclarion is trading at $0.03 per share.

What is the 52-week range for Aclarion?

Over the past 52 weeks, Aclarion has traded between $0.02 and $0.23.

How much debt does Aclarion have?

Aclarion total debt is unavailable.

How much cash does Aclarion have on hand?

Aclarion does not have cash on hand data available.

What is Aclarion’s dividend yield?

Aclarion does not currently have a dividend yield.

Aclarion(NASDAQ) ACONW

Aclarion Financials at a Glance

ACONW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aclarion

ACONW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aclarion Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACONW

What is the current price of Aclarion?

What is the 52-week range for Aclarion?

How much debt does Aclarion have?

How much cash does Aclarion have on hand?

What is Aclarion’s dividend yield?

Premium Investing Services